Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Ardelyx Community
NasdaqGM:ARDX Community
1
Narratives
written by author
0
Comments
on narratives written by author
77
Fair Values set
on narratives written by author
Create a narrative
Ardelyx
Popular
Undervalued
Overvalued
Community Investing Ideas
Ardelyx
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Omnichannel Investments And Sales Teams Will Create Future IBSRELA Demand
Key Takeaways Strategic investments and an expanded sales team are expected to drive demand for IBSRELA, boosting revenue and market share. A strong cash reserve and pipeline development support future growth, aiming to enhance long-term profitability and earnings.
View narrative
US$10.75
FV
49.3% undervalued
intrinsic discount
23.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
ARDX
ARDX
Ardelyx
Your Fair Value
US$
Current Price
US$5.45
45.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-158m
825m
2015
2018
2021
2024
2025
2027
2030
Revenue US$825.3m
Earnings US$163.0m
Advanced
Set Fair Value